James J. Harding - Concepedia

Author

James J. Harding

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Graham, Donna M, Harding J, Hiroshi Onoda, J Harding, J. Harding, J. J. Harding, J.J. Harding, James Harding, James J Harding, James J. Harding

543

Publications

17.3K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute University of California, San Francisco

About

James J. Harding is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	46	7.2K
2	Health Sciences	10	10	4.4K
3	Cell Biology	9	9	1.1K
4	Natural Sciences	1	1	12
5	Biology	1	1	12

James J. Harding

107

Publications

15.7K

Citations

H-Index

Page 1

	Year	Citations
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients Ahmet Zehir, Ryma Benayed, Ronak Shah, Nature Medicine Metastatic CancerOncologySomatic VariantMutational LandscapeTumor Heterogeneity	2017	3.4K
OncoKB: A Precision Oncology Knowledge Base Debyani Chakravarty, Jianjiong Gao, Sarah Phillips, JCO Precision Oncology	2017	2.6K
HER kinase inhibition in patients with HER2- and HER3-mutant cancers David M. Hyman, Sarina A. Piha‐Paul, Helen Won, Nature Tumor BiologyOncologyMedicineReceptor Tyrosine KinasePathology	2018	752
CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC) Thomas Yau, J.W. Park, Richard S. Finn, Annals of Oncology HepatologyMedicineCheckmate 459Liver CancerAdvanced Hepatocellular Carcinoma	2019	639
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Cell UrologyTumor HeterogeneityMedicineNext-generation SequencingPathology	2022	608
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies James J. Harding, Subhiksha Nandakumar, Joshua Armenia, Clinical Cancer Research	2018	568
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention Maeve A. Lowery, Ryan Ptashkin, Emmet Jordan, Clinical Cancer Research	2018	553
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma Lipika Goyal, Lei Shi, Leah Y. Liu, Cancer Discovery	2019	363
<scp>PROSPER</scp>: a randomised comparison of surgical treatments for rectal prolapse Apurbalal Senapati, Richard Gray, Lee Middleton, Colorectal Disease	2013	272
First-in-Humans Imaging with <sup>89</sup>Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting Neeta Pandit‐Taskar, Michael A. Postow, Matthew D. Hellmann, Journal of Nuclear Medicine	2019	249

Page 1